Blood Pressure and Safety Events With Vericiguat in the VICTORIA Trial

Blood Pressure and Safety Events With Vericiguat in the VICTORIA Trial

Background Although safety and tolerability of vericiguat were established in the VICTORIA (Vericiguat Global Study in Subjects With Heart Failure With Reduced Ejection Fraction) trial in patients with heart failure with reduced ejection fraction, some subgroups may be more susceptible to symptomati...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Carolyn S. P. Lam, Hillary Mulder, Yuri Lopatin, Jose B. Vazquez‐Tanus, David Siu, Justin Ezekowitz, Burkert Pieske, Christopher M. O’Connor, Lothar Roessig, Mahesh J. Patel, Kevin J. Anstrom, Adrian F. Hernandez, Paul W. Armstrong
Formato: article
Lenguaje:EN
Publicado: Wiley 2021
Materias:
blood pressure
heart failure
heart failure with reduced ejection fraction
safety events
vericiguat
Diseases of the circulatory (Cardiovascular) system
RC666-701
Acceso en línea:https://doaj.org/article/746573cb9e5446779c083cce06f77a82
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!

Internet

https://doaj.org/article/746573cb9e5446779c083cce06f77a82

Ejemplares similares